AFTAB POSHNI: Open Payments
NPI 1821097924 · CRYSTAL LAKE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,362 in 99 payments from 15 companies in 2025. Trend: 2023 $2,409 · 2024 $2,600 · 2025 $2,362
Food & beverage: $2,362
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $488 |
| ABBVIE INC. | 22 | $369 |
| Neurocrine BioSciences, Inc. | 16 | $365 |
| Teva Pharmaceuticals USA, Inc. | 10 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $204 |
| Otsuka America Pharmaceutical, Inc. | 4 | $117 |
| Lundbeck LLC | 4 | $100 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Axsome Therapeutics, Inc. | 4 | $84 |
| Collegium Pharmaceutical, Inc. | 4 | $79 |
Products named: FANAPT, VRAYLAR, INGREZZA, CAPLYTA, UZEDY, REXULTI, AUSTEDO XR, Auvelity.
Industry payments across IL — which companies pay providers there.
